Table 4 Baseline and last follow-up data
Variables | No diabetes (n = 134) | Diabetes (n = 67) | p value |
|---|---|---|---|
NYHA class III or IV, n | |||
 Baseline | 104 (77.6%) | 54 (80.6%) | 0.63 |
 Last follow-up | 6 (4.5%) | 7 (10.4%) | 0.11 |
Pulmonary hypertension, n | |||
 Baseline | 17 (12.7%) | 5 (7.5%) | 0.26 |
 Last follow-up | 3 (2.2%) | 7 (10.4%) | 0.02 |
NSVT, n | |||
 Baseline | 15 (11.2%) | 15 (22.4%) | 0.04 |
 Last follow-up | 2 (1.5%) | 5 (7.5%) | 0.04 |
LVOT gradient, mmHg | |||
 Baseline | 83.3 ± 26.3 | 93.2 ± 36.8 | 0.03 |
 Last follow-up | 11.6 ± 8.4 | 12.2 ± 8.5 | 0.64 |
Left atrium ≥ 45 mm, n | |||
 Baseline | 47 (35.1%) | 33 (49.3%) | 0.05 |
 Last follow-up | 37 (27.6%) | 17 (25.4%) | 0.74 |
 Death, n | 4 (3.0%) | 5 (7.5%) | 0.16 |
 Sudden cardiac death, n | 0 (0%) | 3 (4.5%) | 0.04 |